The insulin receptor contains an a subunit with insulin binding properties and a ( subunit with insulin-stimulated tyrosine kinase function. Preparations containing insulin and insulinlike growth factor I (IGF-1) receptors were obtained from solubilized human red cell membranes by affinity chromatography. After separate assays for insulin binding and insulin-stimulated tyrosine kinase activities, a high degree of correlation was found between these activities in preparations from normals and diabetics. Identical studies using IGF-1 as the ligand showed a lesser degree of correlation. We compared 24 normal subjects and 14 untreated type II diabetics and found significant diminution in the slope of the line coupling insulin binding and insulin-stimulated kinase activities in the diabetics. This difference was not observed in a similar study of IGF-1-related activities. Compared to normal controls, untreated type II diabetics have reduced tyrosine kinase activity stimulated per unit insulin binding.
Introduction
The detailed mechanism by which insulin binding to its receptor results in the various biologic actions of insulin is unknown. The insulin receptor, composed of two subunits, is believed to contain the necessary information to signal the initiation ofthese events; insulin binding "activates" this signal (1) . The a subunit contains the major insulin binding region of the receptor, and the proposed cDNA sequence for this subunit suggests that it is totally extracellular (2, 3) . The # subunit contains a tyrosinespecific protein kinase (4) and is autophosphorylated; this subunit is a transmembrane protein (2, 3, 5) . Interest in the insulin receptor has focused on the kinase function of the ,3 subunit, either as the means for coupling insulin binding to insulin-induced effects or as a parallel manifestation of the coupling process. Under these circumstances it may relate to only a limited number of effects.
Studies of insulin receptors isolated from circulating cells of patients with extreme insulin resistance have revealed dissociations in the binding (a subunit) and the protein kinase (# subunits). Grunberger et al. described a markedly reduced tyrosine kinase activity in lectin-purified monocyte insulin receptors, despite the presence ofnormal insulin binding, in monocytes from such a patient (6) . Grigorescu 
et al. reported a similar finding
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Receivedfor publication 13 August 1985 and in revisedform 24 September 1986. with solubilized red cell ghost insulin receptors in a different patient with near-normal red cell insulin binding (7) .
Up until now, clinical studies of the (3 subunit of the insulin receptor have been largely restricted to these unusual patients with extreme forms of insulin resistance. This is due in part to methodologic problems in studying patients with possibly more subtle defects. We have developed an assay system to permit the semiquantitative study of the activities of each of the subunits ofthe insulin receptor isolated from red blood cells. This system allows facile comparison of different patient groups. We have chosen the erythrocyte for study because of the large number of insulin receptors obtainable from modest amounts ofblood and have used lectin affinity purification and concentration of these receptors to facilitate study of the receptors. Using these methods, we observed an alteration in the relationship of insulin binding and insulin-stimulated tyrosine kinase activity in preparations from type II diabetics compared with normal subjects. Untreated type II diabetics show a significant reduction in the rate of tyrosine kinase activity stimulated by insulin per unit insulin binding activity when compared with normal controls.
Methods
Material. All reagents were of standard laboratory grade. The following reagents were purchased for these studies: Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ), lectin-agarose beads (E. Y. Laboratories, Inc., San Mateo, CA), wheat germ agarose beads (Miles-Yeda, Rehovot, Israel), porcine insulin (Elanco, Indianapolis, IN), monoiodinated A-14 receptor grade porcine '25I-insulin and [32-P] adenosine triphosphate (New England Nuclear, Boston, MA), aprotinin (Boehringer Mannheim Biochemicals, Indianapolis, IN) and Triton X-100 (New England Nuclear). (> 10%, normal < 8.8%), were studied (eight males and six females, ages 35-56). All patients were either untreated or taken offsulfonylurea therapy with consent for 7-10 d. The data for all subjects are shown in Table I .
Preparation ofsolubilized red blood cell membranes. Red blood cell ghosts were prepared as described by Grigorescu et al. (8) with the following modifications. Samples of 100 ml of blood were drawn into heparinized tubes and diluted 1:2 with normal saline. The diluted blood was layered over Ficoll-Hypaque gradients and centrifuged at 1,000 g for 35 min at room temperature or 10 min at 4°C. The monocyte layer and plasma were aspirated away from the red cell pellet, which was resuspended in normal saline and recentrifuged over Ficoll-Hypaque at 4°C for 10 min at 1,000 g. The supernatant was discarded and 5 ml of the red cell pellet were withdrawn for intact red cell insulin binding. Microscopic examination of these aliquots showed absence of white cell contamination. The remaining red cell pellet (-45 ml) was suspended in Lectin purification. We tested several agarose-fixed lectins for their ability to reversibly bind the solubilized red blood cell insulin receptors and concentrate them. Red blood cell membranes solubilized in 1% Triton X-100 were divided into equal aliquots and passed twice over l-ml columns of agarose-bound lectins prepared according to Hedo (9) . The flow-through was collected. The columns were washed with 40 column volumes of 150 mM NaCl, 50 mM Hepes and 0.1% Triton X-100. The glycoproteins were eluted with the same buffer containing the specific sugar for the lectin in the column (see Table II ). The carbohydrate eluates were compared with the original solutions and the flow-through for insulin binding per 40 Ml of material as described under Binding Studies. The lectins studied, the elution sugar solutions, and the results ofthe binding studies are shown in Table II . From these experiments, ricin II was chosen as the lectin for partial purification and concentration of the red blood cell insulin receptors.
2-ml columns of ricin II attached to agarose beads were used for all samples. These columns demonstrated consistent extraction of 60-80% of the specific insulin-binding activity per 80 Ml found in the solubilized red blood cell membrane preparations as assessed by comparison with flow-through binding. The ricin II columns also showed a consistent ability to concentrate insulin-binding activity per unit volume over that found in solubilized erythrocyte ghost preparations. During the preparative use of the columns, 2-ml fractions of the 0.1 M lactose eluate were collected. The peak of binding activity per 80 Ml usually appeared in fraction 3. The fractions were collected, assayed for specific '25l-insulin binding, and the fraction containing the greatest amount of binding activity was used for the tyrosine kinase assay.
Binding studies ofwhole red blood cells. Insulin binding to intact red blood cells was performed according to the procedure of Ghambir et al. (10) . In brief, red blood cells purified over consecutive Ficoll-Hypaque gradients were washed one time in buffer G and incubated at 15'C for 90 min with varying concentrations ofunlabeled insulin (0-100,000 ng/ ml) and 0.1 ng/ml of '25I-insulin (10,000 cpm) . All data were expressed as bound insulin/free insulin per 4.5 X 109 cells.
Binding studies ofsolubilized and lectin-purified preparations. Insulin binding to all solubilized membrane preparations was performed as previously described (11) . 80-Ml aliquots of the solubilized membranes or lectin-purified preparations were incubated at 4VC for 24 h in buffer adjusted to 0.4% Triton X-100 and containing 150 mM NaCI, 50 mM Hepes, 1 MM PMSF, 0.1 ng/ml of 1251I-labeled insulin (10,000 cpm), andvarying concentrations of insulin (0-10,000 ng/ml) in a total volume of 200 ,l. Bound insulin was separated from free insulin with 12.5% final concentration of polyethylene glycol (PEG) and the pellet was washed one time with PEG before counting. The specific insulin-binding activity IGF-I binding studies were performed in an identical fashion, using '25I-IGF-I (10,000 cpm, 0.1 ng/ml) and varying concentrations (0-10,000 ng/ml) of unlabeled IGF-1. Heterologous ligand competition curves (125I1 insulin competed by unlabeled IGF-l and '251-IGF-l competed by unlabeled insulin) were also performed.
Autophosphorylation ofthe insulin receptor. The ability ofthe insulin receptor to phosphorylate its own i3 subunit was tested as described previously (12) . 250-Ml aliquots ofsolubilized membrane or ricin II-purified preparations were used, and immunoprecipitation of the labeled insulin receptor was carried out with human anti-insulin receptor antibody. Artificial substrate assay ofthe tyrosine kinase activity ofthe insulin receptor. Appropriate conditions for assaying the tyrosine kinase activity ofricin II-purified erythrocyte membrane preparations were determined with the method of Grunberger et al. ( 13) . These experiments were performed with the artificial substrate polyGT. 20 Ml of preparation was incubated with or without insulin in a total volume of 30 Ml in 50 mM Hepes at room temperature. The artificial substrate, polyGT, was then added to a final concentration of 2.5 mg/ml, along with MgCl2, ATP (100 MM final) and yy32P ATP (0.5 MM final) in a total volume of 80 Ml. The reaction was stopped by spotting 60 Ml of reaction mixture on 2-cm squares of filter paper and immersing the papers in 10% trichloroacetic acid containing 10 mM sodium pyrophosphate. All assays were done in duplicate and repeated a second time for verification. Studies for IGF-l stimulation of tyrosine kinase activity were performed in a similar fashion.
Tyrosine kinase activity was linear over at least 30 min (usually to 90 min), required 30 min of preincubation with insulin at room temperature and 20 mM Mg2" for full activation of the activity, and had a maximal response to 10-6 M insulin ( Fig. 1 ) and 10-8 M IGF-1. Addition of excess unlabeled ATP after 15 min of reaction to stop incorporation of 32p into the artificial substrate was followed by loss of 15-25% of the label over the ensuing 15 min (data not shown) with no difference between preparations from normal or diabetic subjects. Addition of 50-100 mM vanadate into the reaction mixture produced no effect (data not shown) on the tyrosine kinase activity of preparations from normal or type II diabetic subjects. Preincubation of labeled insulin with the lectin-purified preparations for 30 min at room temperature and followed by addition of trichloroacetic acid (final concentration 10%) resulted in recovery of > 90% of the label in the precipitate from both normal and diabetic preparations. The addition of 100 MM CTP to the reaction mixtures for normals or diabetics had no consistent effect upon kinase activity nor a different effect between the two types of preparations. There was no measurable ATPase activity in the ricin II-purified preparations.
These studies were used to select assay conditions (30-min room temperature preincubation with insulin, 200 mM MgCI [final] , and 15 min reaction time) for determination of tyrosine kinase activity. All studies were performed with I0-M insulin rather than 10 M to allow comparison with other studies using monocytes and fibroblasts in our laboratory. Tyrosine kinase activity of the insulin receptor is expressed as picomoles of phosphate incorporated in 15 min per milligram of polyGT per 20 ,l of preparations. Stimulated tyrosine kinase activity is the difference between the activity of a preparation in the presence and absence of the stimulating ligand. IGF-J studies. 10 preparations from the normal subjects and seven preparations from the diabetic patients were subjected to binding and kinase assays with biosynthetic IGF-I as ligand. The dose response curve for IGF-I stimulation of phosphorylation of polyGT showed a maximal response at i0-8 M IGF-1 under identical conditions to those used for insulin.
Insulin at 10-1 M and IGF-l at 10-8M were not additive in their 10 20 Mg +2 (mM) ability to stimulate phosphorylation of polyGT under these assay conditions (data not shown).
Binding and kinase studies under identical conditions. Five preparations from normal individuals and five from untreated type II diabetics were studied in both binding and kinase assays under identical buffer and temperature conditions. The buffer contained 150 mM NaCl, 50 mM Hepes, 0.1% Triton X-100, 10 mM bacitracin, and 1 Mg/ml ofaprotinin. Equilibrium binding of insulin was attained in this buffer in 3 h at room temperature, with < 10% degradation oflabeled insulin. Kinase and binding assays were performed as described above after simultaneous 3-h incubation with insulin at room temperature to assess insulin dose response for activation of tyrosine kinase activity at 10-8 M, and 10-7 M as well as insulin binding curves.
Protein determinations. Proteins were determined with the Bio-Rad assay modified for the amounts of Triton X-100 present. The protein concentrations of the solubilized red cell ghosts were 1-3 mg/ml. The ricin II-purified material had protein concentrations of 50-150 Mg/ml. Data analysis. Data were compared by Wilcoxon rank sum test except for comparison of regression lines, for which t tests were used.
Results
Correlation of insulin-stimulated tyrosine kinase activity and specific insulin binding for Ricin II-purified solubilized erythrocyte preparations. The tyrosine kinase activity stimulated by l0-7 M insulin over 15 min at room temperature and the specific 1251I-insulin binding at 4°C of the ricin II-purified erythrocyte preparations were determined for 24 normal and 14 type II diabetic subjects. A linear correlation for tyrosine kinase activity and insulin binding was demonstrated for normal subjects, (r = 0.91, P < 0.05) (Fig. 2 A) . (Fig. 2 B) , the calculated slope of this correlation (53.0 pmol 32p per mg polyGT per unit binding [B/F]) was reduced 42.8% compared with the slope calculated for normal subjects. Because the intercepts for each regression were not significantly different from 0, the lines were recalculated to pass through the origin (Fig. 4  A) . The correlation coefficients for the lines passing through 0 are 0.96 for normals and 0.93 for diabetics. The average kinase activity per unit binding activity is 118±16 for normals and 68±11 for diabetics, as shown in Fig. 4 B. In all three ways of expression (regression, regression through the origin, or average kinase-to-binding ratio), a significant difference is present in the relationship of kinase and binding activity when diabetics are compared with normals. The average kinase activities before and after correction for insulin binding are shown in Table III (Fig. 4 A) , suggesting comparable insulin-binding affinity. Similar results were obtained for studies comparing the solubilized ricin II-purified preparations in these two groups. The average specific binding of 125I-insulin was slightly different (B/F = 0.031 for normal and 0.032 for type II diabetic subjects) but the insulin binding competition curves were comparable (Fig. 4 B) . Competition inhibition studies of ricin II-purified material from normal subjects with insulin analogues showed insulinbinding affinities for chicken insulin and proinsulin typical of the human insulin receptor (Fig. 5) . The affinity of the ricinpurified material was five times greater for chicken insulin and 90 times less for proinsulin than for porcine insulin.
Competition binding studies in which 1251-labeled insulin was competed by unlabeled IGF-1 and 1251-labeled IGF-1 was competed by unlabeled insulin yielded results consistent with the presence of both insulin and IGF-I receptors in these preparations (Fig. 6 ).
Insulin-stimulated autophosphorylation ofthe insulin recep- tor. Fig. 7 shows the insulin stimulation of the phosphorylation ofthe immunoprecipitated p subunit ofthe insulin receptor (Mr -95 kD) in a sample before and after ricin II purification. The stimulation of autophosphorylation of the ft subunit by insulin is more clearly seen in the ricin II-purified material due to the removal of nonstimulated phosphoproteins and a general decrease in retained background radioactivity. Only one major phosphoprotein band is observed in ricin II-purified material immunoprecipitated with anti-insulin receptor antibody.
Comparison ofinsulin-stimulated tyrosine kinase activity and binding activity under identical conditions. The average insulin binding results (B/F) for ricin II preparations studied at room temperature (n = 5 in each group) were 0.0052±0.0006 for normals and 0.0083±0.0013 for diabetics. The average tyrosine kinase activities stimulated by insulin were 1.16±0.15 for normals and 0.87±0.29 for diabetics at 10-7 M insulin, and 1.20±0.22 for normals and 1.00±0.24 for diabetics at 10-8 M insulin (in picomoles 32P per mg polyGT per 15 min). Fig. 8 shows these results in average kinase activity per unit binding X 10-2. The data indicate a significant decrease in tyrosine kinase activity stimulated by insulin per unit of insulin binding in diabetics compared with normals under these conditions using i0-7 M insulin as the stimulatory ligand concentration (240.0±50.0 for normals vs. 145.0±50.0 for diabetics, a 37.5% reduction). Moreover, a similar decrease was also observed with 10' M insulin as the stimulatory ligand concentration.
Discussion
We have described methods for partial purification of human erythrocyte insulin receptors and quantitative comparisons of Figure 5 . Insulin binding inhibition studies with insulin analogues for ricin II-purified erythrocyte insulin receptors from normal subjects. Insulin binding was performed at 4VC for 24 h in the presence of PMSF as described in Methods. '25l-porcine insulin (0.1 ng/ml) was displaced 50% at concentration of 1.4 ng/ml of chicken insulin (n = 1), 12 ng/ml of porcine insulin (n = 14), and 700 ng/ml of proinsulin (n = 2) for ricin II-purified erythrocyte insulin receptors. Standard deviations are shown. the biochemical properties of these preparations from two different groups. One major finding of this study is the demonstration of a correlation between binding (a subunit function) and tyrosine kinase activities (13 subunit function) of solubilized erythrocyte insulin and IGF-1 receptors from normal subjects. We define the slope of the line describing this correlation for each ligand as "coupling" between the a and 13 subunits. The other major finding is a statistically significant difference in the slopes in the lines of correlation between insulin related a and 13 subunit functions of the normals and untreated type II diabetics. We define this as altered coupling with respect to insulin between the a and 1 subunit function of the untreated type II diabetic as compared with the normal.
In standardizing our data the specific binding was positively correlated with the kinase activity of the preparations in the absence (r = 0.77) and the presence of insulin (r = 0.85) but was best correlated with the actual kinase activity stimulated by insulin (r = 0.91). There was little correlation ofbinding activity and protein concentration.
The B/F ratio for insulin binding is theoretically proportional to the number of receptors present for a given set of conditions. The use of B/F as a means to standardize the comparison of data is supported by the similarity of the binding curves For examination of data from individuals or small numbers of patients, the kinase activity per unit binding is a convenient approximation of the correlation (Tables III and IV) . Our type II diabetic patients were untreated at the time of study and differed from the normals in at least three obvious ways: they were hyperglycemic, had a greater average weight, and were somewhat older (Table I) . Examination of the subset of normal and obese individuals who were older than 45 yr at the time of study did not show a significant difference from normals in six out of seven cases. Examination of a separate group of obese normal subjects (Tables I and III) also revealed no difference in the coupling of insulin binding and insulinstimulated kinase activities from normal weight subjects. There was no difference in data obtained from male or female subjects. We conclude that the differences observed between normal and diabetic subjects are not explained by differences in age or weight.
The insulin receptors of erythrocytes have been shown to be qualitatively similar to receptors ofother cell types (10) . Because mature erythrocytes are anucleate and incapable ofprotein synthesis, they are less responsive to physiologic manipulations of insulin, as assessed by intact red cell insulin binding (14, 15) .
The biochemical functions of the a and ft subunits appear to be similar to those of insulin receptors from other cell types (6) . Intact cell binding studies for a given individual, however, give similar results to those obtained from mononuclear blood cells (15, 16) . Erythrocytes have been shown to express fewer insulin receptors on the cell surface with advancing cell age (17). All subjects in this study had normal hematocrit and reticulocyte counts, suggesting normal red cell age distributions. The insulin binding ofpreparations isolated from normal subjects or diabetics were not significantly different (Table III) .
IGF-1 receptors on red blood cells have recently been characterized (18, 19) . Our preparations after ricin II purification contain both insulin and IGF-l receptors as characterized by binding studies (Figs. 5 and 6 ) and specific immunoprecipitation of the insulin receptor 13 subunit by low titers ( 1:100) of antiinsulin receptor polyclonal antibodies (Fig. 7) . The dose ofinsulin used in this study, l0-7 M, has been reported to cause submaximal stimulation of solubilized lectin-purified IGF-l receptor kinase activity towards polyGT under experimental conditions similar to those used in our study (20, 21) . However, when we added maximally stimulating doses of insulin to erythrocyte receptor preparations along with maximally stimulated doses of IGF-1, no significant increase in kinase activity was observed. These results suggest that l-7 M insulin or 10-8 M IGF-l stimulate maximal activity from both populations of receptors in each preparation. Although kinase activity and the B/F ratio for IGF-I binding were correlated, this correlation was not different between normal and diabetic subjects. In fact, the slope of this correlation defining coupling for IGF-1 was greater for diabetics than normals, although not to a significant degree. This trend is opposite that found for insulin. Though our ricin II-purified preparations contain both insulin and IGF-1 binding sites, the difference in the slopes of the relationship between binding and stimulated protein kinase activity is seen only when expressed in terms of insulin binding. Moreover, a similar difference between the normal and diabetic populations was observed using 10-8 M insulin as the stimulatory ligand concentration (Fig. 8 ).
This observation also suggests that the insulin receptors are responsible for most of the differences seen, because the IGF-l receptor kinase is less activated at this concentration of insulin (20 Solubilized erythrocyte membrane preparations before and after ricin IT-purification have similar insulin binding competition curves (data not shown). There was no difference in the percent binding activity retained by the ricin II lectin between normal and type II diabetic patients. We cannot exclude a selection bias in our data introduced by the use of lectin purification, but we feel that this is minimal because > 60% of the binding activity was retained in all instances and all samples received identical treatment.
Lectin agarose beads have proved a useful tool in the purification and concentration of membrane glycoproteins and glycolipids (9) . The insulin receptors of most cell types can be quantitatively recovered after adsorption to wheat germ agglutinin agarose beads (1 1). The erythrocyte insulin receptor is not efficiently recovered using the wheat germ lectin but is satisfactorily recovered using ricin IT (Table TI) . The specificity of lectin binding is complex, involving recognition of individual residues, specific glycosidic linkages or oligosaccharide groups (22) . In general, wheat germ agglutinin binds to sialic acid residues, while ricin II binds to mannose residues. The erythrocyte insulin receptors may be poorly retained by wheat germ agglutinin due to failure to adhere or failure to compete with more heavily sialated components ofthe red cell membrane (i.e., glycophorin).
In a preliminary experiment to examine this issue, serial passage of solubilized red cell membranes over sequential wheat germ agglutinin agarose beads failed to improve retention of insulin binding activity, suggesting that the poor adherence of these receptors per se results in poor retention (data not shown, R. J. Comi). The red cell insulin receptor may be desialated, although removal of sialic acid residues by neuraminidase treatment of the a subunit of these receptors can be demonstrated (23) .
Ricin II purification of solubilized red cell membranes results in at least a 10-fold purification and concentration of binding activity. In Fig. 7 , ricin TI-purified preparations show a decrease in background retention of radioactive label and removal of several nonspecific phosphoproteins. Insulin degrading activity ofthese preparations is significantly reduced compared with solubilized preparations without ricin II purification. In the absence of ricin II purification, assays of kinase activity with polyGT were found to have enormous background activities and inconsistent stimulation of the kinase activity by insulin. For these reasons, ricin II purification significantly facilitates the study of these receptors.
The conditions chosen for this study, binding at 4VC and kinase activity elevated by 10-' M insulin, were selected to allow maximum accuracy and reproducibility. Although a similar difference between preparations from normal and diabetic groups could be shown under identical buffer and temperature conditions ( Fig. 8 ) and also at lower more specific insulin concentrations (10-8 M rather than l0-7 M), there is a greater degree of nonspecific binding at the higher temperature and a lesser stimulation ofkinase activity over basal activity with more prolonged preincubation. Thus, we prefer standard well-characterized assays to allow the most reliable correlation of binding and kinase activities.
The use of the substrate polyGT to measure tyrosine kinase activity has many advantages over measurement of autophosphorylation ofthe # subunit as a measure ofthe kinase function of the insulin receptor (12, 13, 24, 25) . Phosphorylation of the tyrosine residues of an external substrate separates the tyrosine kinase activity of the insulin receptor from its function as a substrate. Because the insulin-binding activity of the insulin receptors is measured separately, the correlation oftyrosine kinase activity stimulated by insulin and specific insulin-binding activity is a measure of the coupling of these two biochemical functions of the insulin-binding receptors. However, assays using polyGT cannot distinguish IGF-l receptor kinase activities stimulated by insulin from those of the insulin receptor.
Previous studies of f subunit function have concentrated on individuals with severe insulin resistance. Grunberger et al. de- scribed a marked reduction in the ft subunit tyrosine kinase of a patient with normal a subunit insulin binding who had type A syndrome of extreme insulin resistance (6). This defect was described for circulating mononuclear cells but has also been found in other cell types from this patient, including red cell insulin receptors (26 (12, 27) . Again, diminution of f3 subunit kinase function paralleled diminution in insulin binding in these two circumstances in patients with extreme insulin resistance.
There have been three recent studies ofquantitative changes in the tyrosine kinase activity of insulin receptors. LeMarchandBrustel et al. described an interesting animal model of acquired insulin resistance and diabetes in chemically induced hyperphagic mice in which diminished # subunit kinase activity of skeletal muscle cell insulin receptors per unit binding per milligram was found for both autophosphorylation and kinase activity towards polyGT (28). This defect developed gradually after induction of the hyperphagic state and parallel with the development ofobesity. This wort suggests that diminished coupling of a and # subunit function may be acquired. Further studies of type TI diabetic patients, whose disease has both genetic and acquired components and who also show defective a and # subunit coupling, may reveal similar findings. Arsenis and Livingston reported diminution of insulin receptor tyrosine kinase activity in rat adipocytes exposed in vitro to high concentrations of insulin (29) . This study demonstrated a 40% reduction in the insulin-stimulated tyrosine kinase activity maximum velocity toward polyGT when expressed per unit ofinsulin binding. This study is particularly relevant to type IT diabetes, because hyperinsulinemia has been described in some of these patients along with a decrease in the binding of 
